Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics

Autor: Richard E. Isaacson, Alexa A. Pragman, Katherine A. Knutson, Shane W. Hodgson, Trevor J. Gould, Cavan S. Reilly, Chris H. Wendt
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
Pulmonology
Physiology
Prevotella
Pathology and Laboratory Medicine
Lung and Intrathoracic Tumors
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
Medicine and Health Sciences
Medicine
COPD
Multidisciplinary
Ecology
Microbiota
Smoking
Genomics
Middle Aged
Body Fluids
Bacterial Pathogens
3. Good health
Shannon Index
Oncology
Medical Microbiology
Laryngeal Mucosa
Female
Anatomy
Pathogens
Simpson Index
medicine.symptom
Research Article
Lung microbiome
medicine.medical_specialty
Ecological Metrics
Chronic Obstructive Pulmonary Disease
Science
Microbial Genomics
Disease cluster
Microbiology
Lung Disorder
03 medical and health sciences
Internal medicine
Genetics
Humans
Microbiome
Microbial Pathogens
Aged
Bacteria
business.industry
Ecology and Environmental Sciences
Sputum
Organisms
Biology and Life Sciences
Streptococcus
Cancers and Neoplasms
Species Diversity
medicine.disease
respiratory tract diseases
Mucus
Nasal Mucosa
030104 developmental biology
030228 respiratory system
Metagenome
Airway
business
Dysbiosis
Zdroj: PLoS ONE, Vol 14, Iss 7, p e0219962 (2019)
PLoS ONE
ISSN: 1932-6203
Popis: BackgroundChronic obstructive pulmonary disease (COPD) is an inflammatory lung disorder associated with lung microbiome dysbiosis. Although the upper airway microbiome is the source of the lung microbiome, the relationships between the oral, nasal, and sputum microbiota are incompletely understood. Our objective was to determine features that differentiate the oral, nasal, and sputum microbiome among subjects with stable COPD.MethodsWe recruited 15 current or former smokers to provide oral and sputum samples on day 1. On day 2, another oral sample and a nasal sample were obtained. Each sample and control underwent DNA extraction, 16S V4 rRNA amplification, 16S V4 sequencing, and qPCR of 16S rRNA. Data were analyzed using dada2 and R.ResultsMost (14 of 15) subjects were male with a mean age of 65.2. One subject had no pulmonary obstruction, while 5 had mild COPD, 7 had moderate COPD, and 2 had severe COPD. Three subjects (20%) were current tobacco users and 2 subjects (13%) used inhaled corticosteroids (ICS). Subjects had a mean of 49.1 pack-years of tobacco exposure. Bacterial biomass was associated with anatomic site, but no differences in biomass were observed with age, FEV1 percent predicted (FEV1pp), ICS use, smoking status, or edentulous state. Shannon index was associated with site (lower nasal diversity than oral and sputum diversity, pConclusionsAmong the upper airway microbiota of COPD subjects, anatomic site was associated with bacterial biomass, Shannon diversity, and β-diversity. ICS use and edentulous state were both associated with β-diversity. Age was associated with taxa relative abundance in oral and sputum samples, while FEV1pp was associated with taxa relative abundance in sputum samples only.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje